Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
Saved in:
| Title: | Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity. |
|---|---|
| Authors: | Pilzer D; Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel., Saar M, Koya K, Fishelson Z |
| Source: | International journal of cancer [Int J Cancer] 2010 Mar 15; Vol. 126 (6), pp. 1428-35. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
